Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Analyst Faisal Khurshid of Leerink Partners maintained a Hold rating on Ironwood Pharma (IRWD – Research Report), retaining the price ...

I don’t foresee major policy-driven changes impacting Indian pharma exports to the US ... Will the act influence Cipla’s manufacturing strategy? The trend of manufacturing closer to the US market ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.

According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

have extensive experience in revenue optimization strategies and execution and GTN automation for Pharma manufacturers of all sizes, business stages, and complexity. Details of IntegriChain's sessions ...

F&O data shows, on Friday Aarti Industries, Aurobindo Pharma and Trent saw a dip in share price alongside rise in open ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...